NCT00006305 - Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes | Biotech Hunter

Enrollment

2,368

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

November 30, 2008

Study Completion Date

March 31, 2009

Conditions

Coronary DiseaseCardiovascular DiseasesHeart DiseasesInsulin ResistanceDiabetes MellitusDiabetes Mellitus, Non-Insulin-Dependent

Interventions

PROCEDURE

Angioplasty, Transluminal, Percutaneous Coronary, other catheter-based interventions

PROCEDURE

Coronary Artery Bypass

DRUG

Biguanides, thiazolidinediones

DRUG

Insulin, sulfonylurea

DRUG

ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Pittsburgh

OTHER